Anatomic Stage III Breast Cancer AJCC v8 Clinical Trials

157 clinical trials for Anatomic Stage III Breast Cancer AJCC v8 across international registries, including 43 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors — RECRUITING · NA
• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer — RECRUITING · PHASE3
• Neoadjuvant Breast Cancer Time Restricted Eating — RECRUITING · PHASE2
• Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer — RECRUITING · PHASE1
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial — RECRUITING · PHASE2
• A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer — RECRUITING · NA
• 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss — RECRUITING · PHASE2
• Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer — RECRUITING · NA
• An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial — RECRUITING · PHASE1
• Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors — RECRUITING · PHASE1
• Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors — RECRUITING · PHASE2
• Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer — RECRUITING · PHASE1
• Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors — RECRUITING · PHASE2
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax — RECRUITING · PHASE1
• Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer — RECRUITING · PHASE1
• Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients — RECRUITING · PHASE2
• Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer — RECRUITING · NA
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors — RECRUITING · PHASE1
• Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial — RECRUITING · PHASE2
• Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial — RECRUITING · NA
• Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer — RECRUITING
• Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial — RECRUITING · NA
• Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy — RECRUITING · PHASE3
• Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer — RECRUITING · PHASE2
• DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients — RECRUITING
• Breast Cancer Survivorship Biorepository — RECRUITING
• Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma — RECRUITING · NA
• Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer — RECRUITING · PHASE2
• Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy — RECRUITING
• Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial — RECRUITING · PHASE3
• A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial — RECRUITING · PHASE2
• Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer — RECRUITING · PHASE2
• Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial — RECRUITING · PHASE2
• Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer — RECRUITING · PHASE2
• Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer — RECRUITING · NA
• Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer — RECRUITING · PHASE1
• Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer — RECRUITING · PHASE2
• Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer — RECRUITING · NA
• Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer — RECRUITING · PHASE1
• The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients — RECRUITING
• Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer — RECRUITING · PHASE2
• Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer — RECRUITING · NA
• Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer — RECRUITING · PHASE2
• Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations — ACTIVE_NOT_RECRUITING · PHASE2
• Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic — ACTIVE_NOT_RECRUITING · PHASE3
• Integrative Approaches for Cancer Survivorship (IACS3) — ACTIVE_NOT_RECRUITING · NA
• Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors — ACTIVE_NOT_RECRUITING

Refine this search